Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients

NCT01042392 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

506

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Aliskiren
DRUG: Ramipril
DRUG: Matching placebo to Aliskiren
DRUG: Matching placebo to Ramipril

Sponsor

Novartis